In an example of foreign investment in the U.S. spurring the creation of manufacturing jobs, the Netherlands-based parts and technology company Zuidberg is opening a distribution center in Cedar Falls, Iowa, according to Area Development. The company will use its American location to store goods that it will ship across the U.S., Canada and Mexico.
"We strongly commit ourselves to the North American agricultural market," said Rudolf de Jong, president of Zuidberg North America Inc. "We are in closer contact with the North American customer base and we will be able to serve the specific requirements in this important area even better. "
De Jong added that he expects there to be an increase in demand for its transmissions product line. The company manufactures machines for agriculture and construction.
Zuidberg first announced the plans for its factory in February of 2014, according to Corridor Business. The company opened in a 10,000 square-foot space in July. Cedar Falls gave a 5-acre parcel of land to the company, along with a five-year property tax exemption to the business that developed the space for Zuidberg.
Bob Seymour, community service manager for the city, said he is thrilled by the company's entrance into the city.
According to Corridor Business De Jong said he appreciated "the great and inspiring help the State of Iowa, the Cedar Valley Alliance & Chamber and local business leaders offered which helped to make the decision easier."
Another foreign company expanding to US
Xellia Pharmaceuticals, a company that specializes in anti-infective treatments, announced it recently purchased Fresenius Kabi's dedicated lyophilized vial manufacturing facility in Raleigh, North Carolina. The factory will continue producing lyophilized vials.
This is Xellia's first plant in the U.S., and it also creates a dramatic increase in its ability to produce injectable pharmaceutical products. The company will keep the 80 staff members currently at the site and it will hire more workers as it expands the facility.
Xellia CEO Carl-Åke Carlsson called the acquisition a major part of its strategy for optimizing its manufacturing chain. Additionally, the company plans to work with Fresenius Kabi in order to ensure that production does not fall as plant ownership transitions.
"This transaction will have no impact on Fresenius Kabi's ability to meet customer demand for the products we currently manufacture at the Raleigh site and we continue to work closely with the FDA to alleviate US drug shortages," Carlsson said.
Businesses that seek to expand their facilities can work with manufacturing recruiters to find the best candidates for their open positions.